OK, while I might agree with some what you've stated and I own a lot this stock and plan to hold through retirement. Still you loose credibility with me stating "Company of the Decade".... R U Serious? Get real.
This company may already have more than enough products. I haven't researched it, but perhaps that is part of the problem... that they need better focus and direction to focus on higher margin and higher sales lines and get rid of some of the rest. Just talking off the top of my head and haven't researched. The other issue is they are very thinly traded and might really benefit most from wining/dining a few analysts to get on their radar, so they build coverage and spread the word. Hopefully they are doing his now, if in fact, they feel confident about executing their growth and profit plans into the future. As a result, I have enough shares for my situation. I consider this small, speculative until the SHOW ME MORE.
Never expected an article like this... GET CNBC TO FIRE CRAMER and the STREET (yah right?).
Problem is nothing will happen to AF and the dirty corrupt firms and perhaps big pharma in bed with him, too... becuase there is NO accountability and justice for all.
I have some VALE and lots of FCX.
I realize VALE may drift lower, but if/when I might add.
I wouldn't want to have all my eggs in that basket, but since you do... you probably will be fine and good to VERY good long-term. Best to you.
A narcissist with a dual-persoanlity disorder cannot ruin a message board or your mode, especially if you do not respond and "ignore" that person. Terrorists are weakened signifacntly when they do not have social media and the press to promote their agenda and fewer people to debate them. Animals go elsewhere for food or will die if they stay in one place if they are not not tossed scraps of food. Ignore and don't feed the animals, especially when they appear rabid.
Enjoying beautiful fall weather and AVNR's share price and possible more good news during Oct and November.
Wondering what long-timers think of likelihood of BO and my point being if there's a EU partnership, doesn't that realistically push any BO way out, unless its more likely by a large big pharma partnering co. Then if there's a big pharma partner, might they rather take a run at ANVR after details of ALZ results and Optinose approval rather than waiting for more trials, phIII's etc?
I'll revisit this board at the next earnings call. I've put my shares in the sock draw right next to the waste basket, although it was tough call where to toss 'em. Disappointed, but mostly just tired... as MHR drifts below six dollars. he only thing worse than MHR's performance is President Obama's pitiful presidency and so many inept clowns that surround him from both parties.
Take care longs. Looking forward to a better 2015 and 2016.
Scripts might bump, but might not. I only say this because if they don't rise much or at all its no big deal, because the news was too soon to impact them. Mostly likely it will take a while until more details are out at conferences, off-label, OPTINOSE, etc...
There were automatic sales at $2s, $4s and $5s. Bet they wish they had let those shares ride.
You could says the same about many companies. MU is another example, There are thousands of examples out there. Besides they have stock options and issues more on yearly.
If the drug works - it works - end of story! AVNR has patent protection and payers will pay. Patients, providers, patient advocates and state/fed reps, senators, congressman will demand it and it will happen. Insurance companies need all the good press they can get.
To many people in LTC today are DRUGED up and sedated. This could dramatically improve quality of life in LTC and reduce the need for expensive LTC beds.
And so what if they did sell some. So long as they kept some. Bottom line I fell better about AVNR's lantern prospects today than 1-2-3-4-5-6.... years ago
That's about it. Live buy the sword and die by the sword. I viewed this as a very speculative play and my only tech play like it. The rest of my tech I sleep very well owning. I plan to reassess at YE14 and listen to Q calls, that's about it. Hopefully there's some better surprise design win announcements over the next six months.
Best to you!
The next 4-8 eight weeks should be very exiting: ALZ Conference details giving MORE exposure to those most QUALIFIED to understand the benefits. Potential OFF-Label. FDA and EU meetings... although no idea how long that process takes (anyone?) Optinose most likely approved. Perhaps EU news and more.
The next four to eight weeks should be exiting between ALZ Conference details and wider exposure to those most qualified to know the benefits and value for ALZ plus Optinose and perhaps EU, etc
Magnum Hunter announces partnership with Morgan Stanley infrastructure on Eureka Hunter; agreement relates to two separate investments by Morgan Stanley Infrastructure (MHR) : Co announced that it has entered into a Transaction Agreement with an affiliate of Morgan Stanley Infrastructure (MS) relating to a separate purchase agreement between MSI and Ridgeline Midstream Holdings, an affiliate of ArcLight Capital Partners, providing for the purchase by MSI of all convertible preferred and common equity interests in Eureka Hunter Holdings owned by ArcLight.
Eureka Hunter is Magnum Hunter's majority owned subsidiary through which various midstream services in West Virginia and Ohio are conducted, including the co's Eureka Hunter Pipeline.
The purchase price of such additional equity interests will be ~ $65 mln, representing an implied equity value of Eureka Hunter of $1.0 bln.
Morgan Stanley takes stake in Magnum Hunter pipeline asset
Sep 16 2014, 08:22 ET | About: Magnum Hunter Resources Cor... (MHR) | By: Carl Surran, SA News Editor Contact this editor with comments or a news tip
Magnum Hunter Resources (NYSE:MHR) says it is bringing in Morgan Stanley as a partner in its Eureka Hunter natural gas gathering subsidiary in the Marcellus and Utica shale fields, giving the two co-ownership in the business valued at $1B.Morgan Stanley Infrastructure (NYSE:MS) agrees to pay $65M to MHR for a 6.5% stake and will buy ArcLight Capital Partners' 41% stake in the business for an unspecified amount.
I was flipping through news and was surprised to see AVNR trending between U.S. bombing IS and 500 Dead in worst boat disaster. Reuters taking this worldwide.
He clearly lost his hair, mind and short shorting AVNR.
What an angry, miserable little troll. Glad he isn't my neighbor and I hope he never breeds.